Skip to main content
graft-versus-host disease

graft-versus-host disease

SyndromeWikipedia

Search complete. 22 mentions across 7 episodes found for "graft-versus-host disease".

Sep 11, 2026

Tim PattonHOST
11:00
Yeah, actually, look, there's only one Treg therapy, I think, that's FDA approved.
Tim PattonHOST
11:06
It's some sort of infusion of Treg cells that you do for like GVHD, right? I mean, that makes sense.
Tim PattonHOST
11:12
Like bad GVHD is horrific.
Tim PattonHOST
11:15
yeah ad and pemphigus and i mean pemphigus is bad but even there was like a t-reg study that that didn't that just closed down i don't know i this this therapy especially when we have all the other things we're going to get we're going to get more jack inhibitors we're going to get long acting like stepica barton we're just going to have so many other therapies i i
Laura FerrisHOST
11:41
It is interesting that this is the disease that they chose to pursue.
Jordan MilnerGUEST
28:21
And we select out the alpha beta T cells, which are 95% of your T cell population.
Jordan MilnerGUEST
28:28
And they're also notorious for causing graft-versus-host disease.
Amanda BradshawHOST
28:32
So we take those puppies out.
Amanda BradshawHOST
28:33
Okay.
Jordan MilnerGUEST
30:07
Uh-huh.
Jordan MilnerGUEST
30:08
And so we're just waiting to see.
Jordan MilnerGUEST
30:10
What I can say is a matched sibling donor transplant comes with a risk of 40% to 60% graft-versus-host disease.
Jordan MilnerGUEST
30:17
Okay.
Ryan LeeGUEST
5:37
There's also a need to really distinguish the different types of transplants, right? An autologous transplant versus an allo.
Ryan LeeGUEST
5:45
And again, we're not going to talk in depth about the CAR T cell therapy, but your risk of developing graft versus host disease is really case by case.
Ryan LeeGUEST
5:55
Patient by patient can be very different.
Ryan LeeGUEST
5:57
But I'm sad to say this.

20 MINS LATER

Ryan LeeGUEST
25:33
So long-term survivorship and oral health for transplant recipients, bone marrow transplant survivors is minimize the invasive stuff and try to hold on to your teeth and gums for as long as possible.
Ryan LeeGUEST
25:45
And while that might sound like cliche and just common sense, please know that your ability to just brush and floss is going to be different.
Ryan LeeGUEST
25:54
In the setting of graft versus host disease, which almost everyone has some degree of, and it's not always a bad thing, that's also an indication that the transplant is working, right?
Peggy BurkhardtHOST
26:02
A
Joanne ClaxtonGUEST
8:10
Yes, yes.
Peggy BurkhardtHOST
8:13
Can you explain what graft-versus-host disease has meant for Adam in everyday life and what people really don't realize regarding living with it?
Joanne ClaxtonGUEST
8:22
Yeah, so graft-versus-host disease is a strange one.
Joanne ClaxtonGUEST
8:26
I mean, it's something I'd never heard of.
Joanne ClaxtonGUEST
8:28
And I mean, I don't think you will have heard of it unless you're sort of on that cancer journey.
speaker_0NARRATOR
0:01
Welcome to Marrowmasters Season 21, sponsored by Insight and Sanofi.
speaker_0NARRATOR
0:06
This season, we'll focus on chronic graft-versus-host disease.
speaker_0NARRATOR
0:10
You'll hear from survivors, clinicians, and more.
speaker_0NARRATOR
0:12
We'll share their experiences, advice, coping mechanisms, updates, and tips so you can enjoy life to the fullest.
Peggy BurkhardtHOST
2:50
Lori, let's talk more about the psychological distress.
Peggy BurkhardtHOST
2:53
What is it and what can survivors do about it?
Lori EberlyGUEST
2:56
I think it's really important that we name that upwards of 30% of people living with chronic graft-versus-host disease report depression or anxiety.
Lori EberlyGUEST
3:06
And I don't say this to be a Debbie Downer.
Mark LevineHOST
13:30
At that time, how successful was the bone marrow transplant? And can you also talk, if you have any information on the alpha beta T cell depletion trial that was part of the transplant?
Jennifer WhiteGUEST
13:45
So the alpha beta T cell depletion is so there's a machine and they use magnetics and it takes the T cells out, which helps prevent like GVHD.
Jennifer WhiteGUEST
13:59
And I think Olivia was the 50th.
Jennifer WhiteGUEST
14:02
child at Children's to do this trial.

5 MINS LATER

Jennifer WhiteGUEST
19:31
So yeah, it can be life-threatening.
Jennifer WhiteGUEST
19:33
But once they understood what it was and started treating it, it was no longer life-threatening as long as she was getting that infusion, weekly infusion.
Mark LevineHOST
19:44
Yeah, I was reading about this alpha-beta T cell depletion I think one of the objectives of it and perhaps hopefully one of the reasons at the time that sounded good that they gave it to you was that the threat of graft versus host disease, GVHD, which is a very difficult disease to get, was the chances of this depletion trial would lessen
Jennifer WhiteGUEST
20:13
the possibility
Colin GrantGUEST
20:56
Yeah, yeah.
Michael RosenHOST
20:56
Graft Versus Host.
Colin GrantGUEST
20:58
Yeah.
Michael RosenHOST
20:58
Which was really interesting, 'cause that, you were going medical on us.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.